Wedbush Trims Day One Biopharmaceuticals Price Target to $32 From $33, Maintains Outperform Rating
Wedbush Trims Day One Biopharmaceuticals Price Target to $32 From $33, Maintains Outperform Rating
Wedbush将Day One生物制药的目标价格从33美元下调至32美元,维持强力推荐评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册